Literature DB >> 833273

Collagen polymorphism in normal and cirrhotic human liver.

J M Seyer, E T Hutcheson, A H Kang.   

Abstract

Collagens in normal human liver and in alcoholic cirrhotic liver were investigated. Collagens were solubilized by limited proteolysis with pepsin under nondenaturing conditions, and after purification, were fractionated into types I and III by selective precipitation with NaCl. After carboxymethyl cellulose and agarose chromatography, the resulting alpha-chains from each of the collagen types were analyzed with respect to their amino acid and carbohydrate compositions. A comparison of the results obtained from normal liver with those from the diseases organ revealed no significant differences. The isolated human liver alpha1(I) and alpha1(III) chains were digested with CNBr and the generated peptides were separated and purified by a combination of ion-exchange and molecular sieve chromatography. The molecular weight and the amino acid and the carbohydrate compositions of each of the peptides were identical to those of the corresponding human skin peptides except for the slightly higher content of hydroxylysine in some of the peptides. The relative content of type III in relation to type I collagen in both normal anc cirrhotic liver was determined by digesting washed liver homogenates directly with CNBr and quantitating the resultant alpha1(I) and alpha 1(III) peptides after chromatographic separation. The relative quantities of these peptides indicated that normal human liver contained an average of 47% type III, with the remainder being type I. Cirrhotic liver, on the other hand, contained a significantly smaller proportion of type III, ranging from 18 to 34% in different samples, with a corresponding increase in type I. These findings indicate that although the amino acid and carbohydrate compositions of collagens deposited in cirrhotic liver are normal, the fibrotic process of alcoholic liver disease in humans is accompanied by an alteration in tissue collagen polymorphism, and suggest that the observed alterations may have pathogenetic implications.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833273      PMCID: PMC333353          DOI: 10.1172/JCI108634

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Pepsin-solubilized collagens of guinea-pig dermis and dermal scar.

Authors:  C A Shuttleworth; L Forrest
Journal:  Biochim Biophys Acta       Date:  1974-10-09

2.  Isolation and characterization of the cyanogen bromide peptides from the alpha 1(3) chain of human collagen.

Authors:  E Chung; E M Keele; E J Miller
Journal:  Biochemistry       Date:  1974-08-13       Impact factor: 3.162

3.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

4.  Human aorta collagens: evidence for three distinct species.

Authors:  R L Trelstad
Journal:  Biochem Biophys Res Commun       Date:  1974-04-08       Impact factor: 3.575

5.  Simple chromatographic method for determination of 14 C-labeled lysine, hydroxylysine, and hydroxylysine glycosides.

Authors:  R S Askenasi; N A Kefalides
Journal:  Anal Biochem       Date:  1972-05       Impact factor: 3.365

6.  Collagen polymorphism: characterization of molecules with the chain composition (alpha 1 (3)03 in human tissues.

Authors:  E Chung; E J Miller
Journal:  Science       Date:  1974-03       Impact factor: 47.728

Review 7.  Hepatic fibrosis. Correlation of biochemical and morphologic investigations.

Authors:  H Popper; S Uenfriend
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

8.  Collagen heterogeneity. High resolution separation of native ( 1(I) 2 2 and ( 1(II) 3 and their component chains.

Authors:  R L Trelstad; A H Kang; B P Toole; J Gross
Journal:  J Biol Chem       Date:  1972-10-25       Impact factor: 5.157

9.  Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing -hydroxylysinonorleucine.

Authors:  A H Kang
Journal:  Biochemistry       Date:  1972-05-09       Impact factor: 3.162

10.  Isolation and characterization of cyanogen bromide peptides from basement membrane collagen.

Authors:  N A Kefalides
Journal:  Biochem Biophys Res Commun       Date:  1972-06-09       Impact factor: 3.575

View more
  40 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo.

Authors:  J J Maher; R F McGuire
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 3.  Hepatic cirrhosis--a collagen formative disease?

Authors:  J O McGee; A Fallon
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

4.  Prolyl 3-hydroxylase and 4-hydroxylase activities in certain rat and chick-embryo tissues and age-related changes in their activities in the rat.

Authors:  K Tryggvason; K Majamaa; K I Kivirikko
Journal:  Biochem J       Date:  1979-01-15       Impact factor: 3.857

5.  Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A.

Authors:  John Fassett; Diane Tobolt; Linda K Hansen
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

6.  Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides.

Authors:  A E Postlethwaite; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

Review 7.  Molecular mechanisms of hepatic fibrosis and principles of therapy.

Authors:  S L Friedman
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

8.  Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.

Authors:  J A Cairns; A F Walls
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

9.  Hydroxyproline and passive stiffness of pressure-induced hypertrophied kitten myocardium.

Authors:  J F Williams; R D Potter; D L Hern; B Mathew; W P Deiss
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.